March 22, 2023
Local 12 highlighted the University of Cincinnati's Bingfang Yan, who recently received a a $2.5 million National Institutes of Health grant to study how COVID-19 therapeutics can work together to create more effective and safe treatments for patients.
April 14, 2023
University of Cincinnati Cancer Center researchers will present more than a dozen abstracts at the American Association for Cancer Research Annual Meeting 2023, held in Orlando, Florida, April 14-19, including findings that could advance treatments for head and neck and breast cancers.
April 14, 2023
The University of Cincinnati Cancer Center's Melinda Butsch Kovacic and colleagues will present research abstracts on several community outreach and engagement initiatives at the American Association for Cancer Research Annual Meeting 2023, held in Orlando, Florida, April 14-19.
March 21, 2023
Amanda Jackson, MD, is the site principal investigator at the University of Cincinnati for the UP-NEXT trial that is testing a new treatment for a subset of ovarian cancer patients.
March 16, 2023
The University of Cincinnati's Bingfang Yan's research team has received a $2.5 million National Institutes of Health grant to answer the question of how FDA-approved COVID-19 therapeutics can work together to create more effective and safe treatments for patients.
March 28, 2023
Researchers led by the University of Cincinnati's Nalinikanth Kotagiri, PhD, have published new research showing proof of concept for using engineered bacteria as an adapter to deliver targeted radionuclide treatment to tumors.
March 29, 2023
University of Cincinnati research on the steroid dexamethasone's effect on immune cells and benefit to severe COVID-19 patients was recently published in Frontiers in Immunology.
April 26, 2023
WFMZ-TV in Allentown, Pennsylvania highlighted the University of Cincinnati's John Byrd and the Beat AML study testing personalized treatment for patients with acute myelogenous leukemia.
April 27, 2023
National outlets including U.S. News & World Report highlighted research presented by the University of Cincinnati's Alberto Espay on promising new treatments for Parkinson's disease.
April 19, 2023
The University of Cincinnati is one of 50 nationwide trial sites for a new clinical trial testing a new treatment for status epilepticus, the most severe and deadly form of epilepsy.